CapyFin

Calendar Reports Pricing

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Neuropace (NPCE) Financial Analysis | CapyFin

Neuropace

NPCE · NASDAQ🇺🇸

Earnings Dividends Seasonality Metrics

Reported earnings 28 days ago

Previous year: $21.5M

Previous year: -$0.18

Gross Profit Margin

Previous year: 75.4%

Adjusted EBITDA

Previous year: -$1M

RNS Gross Margin

Previous year: 80.1%

Previous year: $16.2M

Cash and Equivalents

Previous year: $13.4M

Previous year: -$4.84M

Previous year: $94.6M

Loading...

Neuropace

Unlock previous datapoints

Neuropace

Unlock previous datapoints

Neuropace Revenue by Segment

Revenue by Segment

RNS System Revenue

CapyFin.com

DIXI Medical Revenue

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$449M

P/E Ratio

-19.44

Sector

N/A

Industry

N/A

52-Week High

$18.1

52-Week Low

$8.23

Gross Profit Margin

77.4%

Adjusted EBITDA

$920K

RNS Gross Margin

80.5%